Pharmaceutical Market - Ways for Creating Competitive Advantage at Zdravko Mauko
This document outlines several ways for pharmaceutical companies to develop competitive advantages in their markets. These include pursuing cost advantages, innovation, intellectual property protection, segmentation, technology leadership, specialization, and partnerships through networks and alliances.
Competitive Analysis in Pharmaceutical IndustryYee Jie NG
Eli Lilly is a global pharmaceutical company founded in 1876. The document analyzes Eli Lilly's competitive position using Porter's Five Forces and SWOT analysis. It identifies key trends in the pharmaceutical industry including mergers and acquisitions, aging populations, expiring patents, and increased regulations. These trends present both opportunities and threats for Eli Lilly. The analysis suggests Eli Lilly should pursue strategies like partnerships, emerging markets, and ongoing R&D to adapt to changes in the competitive landscape over the next 10 years.
Pharmaceutical Industry Environmental Analysis (Sanofi, Merck & Co.)Steven Sabo
The document is a letter of transmittal from a team of students to their professors submitting a report analyzing the global pharmaceutical companies Merck & Co. and Sanofi. The team's analysis identified three key success factors for companies in the industry and concluded that based on these factors, Sanofi is currently in a better position than Merck & Co. to succeed. The letter requests feedback from the professors and offers to further discuss the report and its analyses and recommendations.
An introduction to email marketing. The presentation provides an overview of email as a marketing tool and looks at the trends, pitfalls and best practices currently employed.
This document discusses strategies for launching new pharmaceutical brands. It outlines that successful product launching depends on coordination across functions. The purpose is to build sales. A launching strategy consists of marketing decisions, activities, and product attributes to present the product to its target market. The objectives are to generate income. Key aspects of launching strategy include being first to market, a first follower, or delayed entrant. Marketing decisions include market entry strategy, product positioning, and marketing mix. Strategic decisions involve company strategy, product strategy, market strategy, and competitive strategy. Tactical decisions involve the marketing mix of product, price, promotion, and distribution. Success depends on customer performance, financial performance, and technical performance. The document provides details on various strategic
This document discusses a marketing plan for Enbrel, a drug produced by Wyeth to treat psoriasis. It provides an overview of Wyeth, describes Enbrel and the psoriasis market in Egypt. It analyzes Enbrel's market share and position, performs a SWOT analysis, and discusses segmentation of the psoriasis market in Egypt. The plan suggests an awareness campaign to educate physicians, insurers and others on benefits of Enbrel to improve patients' quality of life and allow them to meet needs beyond just basic physiological requirements.
Pharmaceutical Market - Ways for Creating Competitive Advantage at Zdravko Mauko
This document outlines several ways for pharmaceutical companies to develop competitive advantages in their markets. These include pursuing cost advantages, innovation, intellectual property protection, segmentation, technology leadership, specialization, and partnerships through networks and alliances.
Competitive Analysis in Pharmaceutical IndustryYee Jie NG
Eli Lilly is a global pharmaceutical company founded in 1876. The document analyzes Eli Lilly's competitive position using Porter's Five Forces and SWOT analysis. It identifies key trends in the pharmaceutical industry including mergers and acquisitions, aging populations, expiring patents, and increased regulations. These trends present both opportunities and threats for Eli Lilly. The analysis suggests Eli Lilly should pursue strategies like partnerships, emerging markets, and ongoing R&D to adapt to changes in the competitive landscape over the next 10 years.
Pharmaceutical Industry Environmental Analysis (Sanofi, Merck & Co.)Steven Sabo
The document is a letter of transmittal from a team of students to their professors submitting a report analyzing the global pharmaceutical companies Merck & Co. and Sanofi. The team's analysis identified three key success factors for companies in the industry and concluded that based on these factors, Sanofi is currently in a better position than Merck & Co. to succeed. The letter requests feedback from the professors and offers to further discuss the report and its analyses and recommendations.
An introduction to email marketing. The presentation provides an overview of email as a marketing tool and looks at the trends, pitfalls and best practices currently employed.
This document discusses strategies for launching new pharmaceutical brands. It outlines that successful product launching depends on coordination across functions. The purpose is to build sales. A launching strategy consists of marketing decisions, activities, and product attributes to present the product to its target market. The objectives are to generate income. Key aspects of launching strategy include being first to market, a first follower, or delayed entrant. Marketing decisions include market entry strategy, product positioning, and marketing mix. Strategic decisions involve company strategy, product strategy, market strategy, and competitive strategy. Tactical decisions involve the marketing mix of product, price, promotion, and distribution. Success depends on customer performance, financial performance, and technical performance. The document provides details on various strategic
This document discusses a marketing plan for Enbrel, a drug produced by Wyeth to treat psoriasis. It provides an overview of Wyeth, describes Enbrel and the psoriasis market in Egypt. It analyzes Enbrel's market share and position, performs a SWOT analysis, and discusses segmentation of the psoriasis market in Egypt. The plan suggests an awareness campaign to educate physicians, insurers and others on benefits of Enbrel to improve patients' quality of life and allow them to meet needs beyond just basic physiological requirements.
- The document provides sales forecasts for Esoz 20, an esomeprazole magnesium tablet, for the first year in quarterly projections. It estimates sales of Rs. 2.5 crore for the year with sales increasing each month and quarter as penetration increases.
- A promotional budget of Rs. 30 lakh is allocated equally across the 4 quarters to market the brand to gastroenterologists, general physicians, surgeons and gynaecologists in metro and class 1/2 cities.
- Key activities include product sampling, branding materials, and print advertisements. Pricing is set at Rs. 15.93 per tablet with a company margin of 60% after trade discounts.
Pharma Plan is a leading international healthcare recruitment consulting company with over 20 years of experience. They specialize in recruiting for the pharmaceutical, biotech, medical devices and diagnostics industries. Their recruitment process involves identifying candidates through their large international network and database, screening candidates, conducting interviews, and guaranteeing candidate placement. They maintain high ethical standards and have a diverse client list of major healthcare companies.
The document provides an analysis of the Pakistan pharmaceutical market. Some key points:
- The total Pakistan pharma market is US$2.177 billion and is growing at a CAGR of 10.22% in US dollars.
- The top 11 corporations have reached Rs. 5 billion in sales and account for 49.22% of the market share.
- Top 50 corporations control 86% of the market and top 100 corporations control 95.95% of the market.
- 398 new products were launched in the last 12 months, with 20 from multinational corporations and 378 from national companies.
Follow our mantra of sending the right message, to the right person, at the right time, with the right frequency as a framework for your email marketing strategy.
This document provides an overview and marketing plan for the launch of the new PPI drug Esomeprazole. The summary is:
1) Esomeprazole is aiming to target the large and growing PPI drug market by positioning itself as the most advanced PPI with higher bioavailability and safety.
2) The marketing plan includes pre-launch market research, targeting physicians and pharmacists with differentiated positioning messages emphasizing Esomeprazole as the "first choice" PPI.
3) Tactics will include sequential physician visits, message-related promotions, and a focus on tenders, competitions management, and direct-to-customer and consumer campaigns. The goal is to achieve the
Your welcome email (or lack thereof) sets the tone for the email marketing relationship you have with your subscribers—make sure it's sending the right message!
This document summarizes a sales promotion campaign conducted by Aventis Pharmaceuticals for their breast cancer drug Taxotere. Aventis faced difficulties promoting Taxotere to oncologists due to busy schedules and FDA regulations limiting sales representative meetings. Their research found that breast cancer patients wanted connections to family/friends during treatment. Aventis created "Connection Cards" gift packs for patients including calling cards, information materials, and coupons. Distributed by sales representatives, the campaign was successful in building relationships with oncologists and providing 60,000 gift packs to patients. Aventis continued the program as a regular communication strategy.
Pitching Ideas: How to sell your ideas to othersJeroen van Geel
Learn how to convince others of your UX ideas by understanding them.
We are good in designing usable and engaging products and services. We understand the user's needs and have a toolkit with dozens of deliverables. But for some reason it remains difficult to sell an idea or concept to team members, managers or clients. After this session that problem will be solved!
Selling your ideas and convincing others is one of the most undervalued assets in our field. This ranges from convincing a colleague to use a certain design pattern to selling research to your boss and convincing a client to go for your concept. You can come up with the best ideas in the world, but if it is presented in the wrong way these ideas will die a lonely dead. This is sad, because everybody can learn how to bring a message across. The main thing is that you know what to pay attention to.
In this session I will take you on a journey through the world of presenting ideas. We will move through the heads of clients and your colleagues, learn what their thoughts and needs are. We will move to the core of your idea and into the world of psychology.
Three business basics to always remember! People don't care about your brand. They care about what you can do for them. Back to basics... Give people what they want, do it consistently and do it better than your competition.
Go Viral on the Social Web: The Definitive How-To guide!XPLAIN
Creating a Viral Content success story has no recipe. It has a lot of variables, not all of which can be controlled by a Brand. However, this deck offers you the ideal How-To approach in creating tasteful, inspired Content that will help your message stand out from the information noise on Social Web and make people eager to share it around.
- The document provides sales forecasts for Esoz 20, an esomeprazole magnesium tablet, for the first year in quarterly projections. It estimates sales of Rs. 2.5 crore for the year with sales increasing each month and quarter as penetration increases.
- A promotional budget of Rs. 30 lakh is allocated equally across the 4 quarters to market the brand to gastroenterologists, general physicians, surgeons and gynaecologists in metro and class 1/2 cities.
- Key activities include product sampling, branding materials, and print advertisements. Pricing is set at Rs. 15.93 per tablet with a company margin of 60% after trade discounts.
Pharma Plan is a leading international healthcare recruitment consulting company with over 20 years of experience. They specialize in recruiting for the pharmaceutical, biotech, medical devices and diagnostics industries. Their recruitment process involves identifying candidates through their large international network and database, screening candidates, conducting interviews, and guaranteeing candidate placement. They maintain high ethical standards and have a diverse client list of major healthcare companies.
The document provides an analysis of the Pakistan pharmaceutical market. Some key points:
- The total Pakistan pharma market is US$2.177 billion and is growing at a CAGR of 10.22% in US dollars.
- The top 11 corporations have reached Rs. 5 billion in sales and account for 49.22% of the market share.
- Top 50 corporations control 86% of the market and top 100 corporations control 95.95% of the market.
- 398 new products were launched in the last 12 months, with 20 from multinational corporations and 378 from national companies.
Follow our mantra of sending the right message, to the right person, at the right time, with the right frequency as a framework for your email marketing strategy.
This document provides an overview and marketing plan for the launch of the new PPI drug Esomeprazole. The summary is:
1) Esomeprazole is aiming to target the large and growing PPI drug market by positioning itself as the most advanced PPI with higher bioavailability and safety.
2) The marketing plan includes pre-launch market research, targeting physicians and pharmacists with differentiated positioning messages emphasizing Esomeprazole as the "first choice" PPI.
3) Tactics will include sequential physician visits, message-related promotions, and a focus on tenders, competitions management, and direct-to-customer and consumer campaigns. The goal is to achieve the
Your welcome email (or lack thereof) sets the tone for the email marketing relationship you have with your subscribers—make sure it's sending the right message!
This document summarizes a sales promotion campaign conducted by Aventis Pharmaceuticals for their breast cancer drug Taxotere. Aventis faced difficulties promoting Taxotere to oncologists due to busy schedules and FDA regulations limiting sales representative meetings. Their research found that breast cancer patients wanted connections to family/friends during treatment. Aventis created "Connection Cards" gift packs for patients including calling cards, information materials, and coupons. Distributed by sales representatives, the campaign was successful in building relationships with oncologists and providing 60,000 gift packs to patients. Aventis continued the program as a regular communication strategy.
Pitching Ideas: How to sell your ideas to othersJeroen van Geel
Learn how to convince others of your UX ideas by understanding them.
We are good in designing usable and engaging products and services. We understand the user's needs and have a toolkit with dozens of deliverables. But for some reason it remains difficult to sell an idea or concept to team members, managers or clients. After this session that problem will be solved!
Selling your ideas and convincing others is one of the most undervalued assets in our field. This ranges from convincing a colleague to use a certain design pattern to selling research to your boss and convincing a client to go for your concept. You can come up with the best ideas in the world, but if it is presented in the wrong way these ideas will die a lonely dead. This is sad, because everybody can learn how to bring a message across. The main thing is that you know what to pay attention to.
In this session I will take you on a journey through the world of presenting ideas. We will move through the heads of clients and your colleagues, learn what their thoughts and needs are. We will move to the core of your idea and into the world of psychology.
Three business basics to always remember! People don't care about your brand. They care about what you can do for them. Back to basics... Give people what they want, do it consistently and do it better than your competition.
Go Viral on the Social Web: The Definitive How-To guide!XPLAIN
Creating a Viral Content success story has no recipe. It has a lot of variables, not all of which can be controlled by a Brand. However, this deck offers you the ideal How-To approach in creating tasteful, inspired Content that will help your message stand out from the information noise on Social Web and make people eager to share it around.
Slide should be filled in by country team under guidance of project team Information may be used to focus activities on most important stakeholders in value chain Information should be based on current information but include expectations on future development Description Espicom country reports (may be available in Sandoz Business Intelligence) WHO: European Observatory on Health System and Policies (http://www.euro.who.int/observatory) Nomura Report on generics in Europe (available in Sandoz Business Intelligence) Sandoz experts Data sources (examples)
StratPlan 2007-12
IMS Precision Sales Force Methodologies. As a result of many hundreds of client engagements where on average only 35% of rep call activity is in the optimal range in terms of targeting and call effectiveness IMS invested in developing a set of best practice methodologies and analytics supported by a sophisticated optimization tool platform and information assets to deliver best in class improvements in Sales effectiveness. From a sample of 50 projects over twelve countries we can see that each stage in the SFE process yields these typical revenue gains. These projects have all taken place in a time when there are changing healthcare market environments and sales models - in particular moving from pure rep detailing of individual prescribers to incorporate new influencers and decision makers such as Primary Care Trusts and Commissioning groups in the UK, sick funds in Germany and County Councils and Polyclinics in Sweden. These changes result in different sales models such as account based selling that further complicate sales force sizes, structures and compensation schemes. As a result IMS continues to invest in information assets, advanced analytics and consulting capabilities to address these complexities. New ways of segmenting the market and metrics such as share of voice per segment as well as Anonymous Patient Level Data are all increasing the understanding of prescribers, their decisions, patient needs and environmental constraints.